XML 22 R1.htm IDEA: XBRL DOCUMENT v3.25.4
Document and Entity Information - USD ($)
 12 Months Ended
Oct. 31, 2025
Dec. 18, 2025
Apr. 30, 2025
Entity Listings [Line Items]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Oct. 31, 2025    
Document Fiscal Year Focus 2025    
Entity File Number 001-41854    
Entity Registrant Name enGene Holdings Inc.    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
ICFR Auditor Attestation Flag false    
Entity Filer Category Non-accelerated Filer    
Current Fiscal Year End Date --10-31    
Document Fiscal Period Focus FY    
Entity Incorporation, State or Country Code A1    
Entity Central Index Key 0001980845    
Entity Tax Identification Number 00-0000000    
Document Financial Statement Error Correction [Flag] false    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Shell Company false    
Entity Address, Address Line One 4868 Rue Levy, Suite 220    
Entity Address, City or Town Saint-Laurent    
Entity Address, State or Province QC    
Entity Address, Country CA    
Entity Address, Postal Zip Code H4R 2P1    
City Area Code 514    
Local Phone Number 332-4888    
Entity Ex Transition Period true    
Entity Public Float     $ 154,176,366
Entity Common Stock, Shares Outstanding   66,984,661  
Documents Incorporated by Reference

DOCUMENTS INCORPORATED BY REFERENCE

Portions of the definitive proxy statement of enGene Holdings Inc. to be filed for its 2026 annual meeting of shareholders are incorporated by reference into Part III of this Annual Report on Form 10-K.

   
Auditor Opinion

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of enGene Holdings Inc. (the Company) as of October 31, 2025 and 2024, the related consolidated statements of operations and comprehensive loss, shareholders’ equity, and cash flows for each of the years then ended, and the related notes (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of October 31, 2025 and 2024, and the results of its operations and its cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles.

    
Auditor Name KPMG LLP    
Auditor Location Montreal, Canada    
Auditor Firm ID 85    
Common Shares      
Entity Listings [Line Items]      
Trading Symbol ENGN    
Title of 12(b) Security Common Shares    
Security Exchange Name NASDAQ    
Warrants, each exercisable for one Common share, at an exercise price of $11.50 per share      
Entity Listings [Line Items]      
Trading Symbol ENGNW    
Title of 12(b) Security Warrants, each exercisable for one Common Share, at an exercise price of $11.50 per share    
Security Exchange Name NASDAQ